LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML

Date
2022-10-10
Advisor
Supervisor
Co-Advisor
Co-Supervisor
Instructor
Source Title
Proceedings of the National Academy of Sciences of the United States of America
Print ISSN
00278424
Electronic ISSN
Publisher
National Academy of Sciences
Volume
119
Issue
42
Pages
1 - 10
Language
English
Type
Article
Journal Title
Journal ISSN
Volume Title
Series
Abstract

Transcription factors (TFs) play critical roles in hematopoiesis, and their aberrant expression can lead to various types of leukemia. The t(8;21) leukemogenic fusion protein AML1–ETO (AE) is the most common fusion protein in acute myeloid leukemia and can enhance hematopoietic stem cell renewal while blocking differentiation. A key question in understanding AE-mediated leukemia is what determines the choice of AE to activate self-renewal genes or repress differentiation genes. Toward the resolution of this problem, we earlier showed that AE resides in the stable AETFC complex and that its components colocalize on up- or down-regulated target genes and are essential for leukemogenesis. In the current study, using biochemical and genomic approaches, we show that AE-containing complexes are heterogeneous, and that assembly of the larger AETFC (containing AE, CBFβ, HEB, E2A, LYL1, LMO2, and LDB1) requires LYL1. Furthermore, we provide strong evidence that the LYL1-containing AETFC preferentially binds to active enhancers and promotes AE-dependent gene activation. Moreover, we show that coactivator CARM1 interacts with AETFC and facilitates gene activation by AETFC. Collectively, this study describes a role of oncoprotein LYL1 in AETFC assembly and gene activation by recruiting CARM1 to chromatin for AML cell survival. Copyright © 2022 the Author(s). Published by PNAS.

Course
Other identifiers
Book Title
Keywords
Acute myeloid leukemia, AML1–ETO, CARM1, E proteins, LYL1
Citation
Published Version (Please cite this version)